Why WHO dropped old age as a diagnosis

How a Fight Over One Diagnostic Label Shows Why the Words for Aging Decide What Gets Studied and Treated

This page is for learning and research. It is not medical advice and does not recommend any drug, test, or clinic.

Why WHO dropped old age as a diagnosis is a story about how a single line in a global code book can either help or hurt the fight against aging. This page serves the futurism and abundance goals of this wiki. Treating the decline that comes with age as something that can be measured and changed, rather than as fate, is part of moving from a world where healthy years are scarce toward one where they are abundant. The thesis is simple. In 2021 and 2022, people who wanted to protect older adults from neglect and people who wanted aging treated as a medical target looked like opponents, yet both got what they needed once the label stopped naming a birthday and started naming a measurable loss of function. The lesson for anyone working on longevity is to fight for codes that describe biology, never for codes that describe a number of years.

What the code book is and why labels matter

The International Classification of Diseases, or ICD, is the shared vocabulary that doctors, hospitals, statistics offices, and health systems use to record why people get sick and why they die. The eleventh revision, ICD-11, was adopted by the World Health Assembly in 2019 and came into effect on 1 January 2022.[1] When WHO announced it, the agency said ICD-11 holds around 17,000 unique codes and more than 120,000 codable terms.[2]

A code is not just a word. What gets coded gets counted, and what gets counted shapes where research money, clinical attention, and policy go. That is why a quiet relabeling inside a section for vague symptoms turned into an international campaign.

From senility to old age

ICD-10 had a category for senility. WHO explains that this label had been in place for about 50 years and that the word senility had picked up a negative meaning over time, so the draft of ICD-11 replaced it with the words old age under the code MG2A. WHO also states that the category was never meant to classify old age as a disease. Its job is quality control: it gives coders a place to put unclear statements that physicians write on death certificates and medical records.[3]

That intent did not settle the matter. Kiran Rabheru and colleagues, writing in The Lancet Healthy Longevity, argued that a label referring to people by an undefined chronological age was open to inappropriate and erroneous use, and that it risked real harm because biological aging and chronological aging are not the same thing.[4] They connected this to ageism during the COVID-19 pandemic, when older people were often left behind in their right to health.[4]

The ageism concern has data behind it. A 2021 United Nations report led by WHO, based on a survey of 83,034 people in 57 countries, found that one in every two people held moderately or highly ageist attitudes. The same report cited a 2020 systematic review in which age determined who received certain medical procedures or treatments in 85 percent of 149 studies.[5]

The campaign and the new wording

Opposition organized quickly across civil society and professional groups. In Brazil, a national campaign ran under a slogan that translates as Old Age Is Not a Disease.[4] In October 2021, the group met with the ICD-11 committee and submitted a formal proposal with three possible replacement terms: senescence, ageing associated decline in intrinsic capacity, and frailty.[4]

WHO adopted the second option. The category is now labeled ageing associated decline in intrinsic capacity, and the phrase old age survives only as an index term so that coders know where to put it when a physician writes it.[3] The authors also report that the word pathological was removed from the definition attached to a related extension code.[4]

The other side of the fight

At the same time, a different group was pushing to bring aging into the code book for the opposite reason. In 2015, Sven Bulterijs and colleagues argued that it is time to classify biological aging as a disease. They pointed out that progeria, a rare condition with features of accelerated aging, is treated as a disease, while similar changes 80 years later are treated as normal. They also noted that conditions such as osteoporosis and sarcopenia are nearly universal in late life and are still classified as diseases needing care.[6]

In 2020, Khaltourina and colleagues applied the disease criteria developed for ICD-11 to biological aging. They argued that aging can be diagnosed with frailty indices and blood-based biomarkers, has described causal mechanisms, and has known interventions. They reported that their proposal to the ICD-11 task force led to the inclusion of an extension code called Ageing-related, numbered XT9T, in the causality section.[7]

The disagreement is not settled. A 2026 paper by Feltes argues from evolutionary and comparative biology that current evidence does not support equating aging with disease in a strict sense. Feltes also writes that the classification question is not relevant to the importance of investing in aging research.[8] An editorial in The Lancet Healthy Longevity described the ICD dispute as a sign of a deeper conflict between longevity science and geriatric medicine over whether ageing can be regarded as a disease.[9]

Why both sides got what they needed

Look at what each camp actually feared and wanted.

  • The anti-ageism camp feared a label that let a clinician stop thinking once a patient passed a certain age. A label about a birthday does that. A label about lost capacity does not, because capacity can be measured, compared over time, and in some cases improved.
  • The longevity camp wanted aging to be visible as a target, so that interventions against the underlying biology could be studied and eventually paid for. A label about lost capacity, plus a causality code for ageing-related conditions, gives them a place to record that biology.

The word that caused the trouble was old, because it described time rather than function. Once the label described decline in intrinsic capacity, it pointed at something a treatment could, in principle, change. That is the same move that helps any research field: name the measurable thing, then try to move it. The challenge of proving that a measurement truly predicts health is covered on Aging clocks.

Why this matters for abundance

Scarcity thinking treats late-life decline as a fixed budget: everyone gets a certain number of healthy years, and medicine only manages the losses. A code book that says old age as a cause of death quietly reinforces that view. A code book that names decline in capacity treats the same years as a problem in living that can be studied, measured, and reduced. Defeating aging as a research and policy fight depends on small, unglamorous wins like this one, because funding agencies, regulators, and health systems all work from the categories they are given.

Honest limits

A change of label does not create a treatment. No drug is approved to treat aging itself, and the new wording does not change that. Coding practice varies by country, many countries still use ICD-10, and the phrase old age is still accepted as an index term, so it can still appear on records. The sources here are commentaries, opinion papers, and WHO statements, not studies of how the change affected real patients. Whether aging should be called a disease remains a live scientific and philosophical dispute, and this page does not settle it.

  • Explain why a label for vague symptoms in a code book could change how older patients are treated in a hospital.
  • Compare the words senility, old age, and ageing associated decline in intrinsic capacity, and describe what each one invites a clinician to do next.
  • Argue whether the longevity movement gains more from calling aging a disease or from coding its measurable parts, using the ICD-11 dispute as evidence.
  • Describe how ageism in health care could interact with any future treatment that slows biological aging, and who might be left out.
  • Design a measurement of intrinsic capacity that a small clinic could use, and explain what would make it trustworthy enough for research.
  • Trace how a single diagnostic code moves from a WHO committee into research funding, insurance decisions, and death statistics.

See also

References

  1. ↑ World Health Organization. "ICD-11 Implementation" (frequently asked questions). https://www.who.int/standards/classifications/frequently-asked-questions/icd-11-implementation
  2. ↑ World Health Organization. "WHO's new International Classification of Diseases (ICD-11) comes into effect." 11 February 2022. https://www.who.int/news/item/11-02-2022-who-s-new-international-classification-of-diseases-(icd-11)-comes-into-effect
  3. ↑ 3.0 3.1 World Health Organization. "Old age" (frequently asked questions). https://www.who.int/standards/classifications/frequently-asked-questions/old-age
  4. ↑ 4.0 4.1 4.2 4.3 4.4 Rabheru K, et al. "How old age was withdrawn as a diagnosis from ICD-11." The Lancet Healthy Longevity, 2022. https://doi.org/10.1016/S2666-7568(22)00102-7
  5. ↑ World Health Organization. "Ageism is a global challenge: UN." 18 March 2021. https://www.who.int/news/item/18-03-2021-ageism-is-a-global-challenge-un
  6. ↑ Bulterijs S, Hull RS, Bjork VCE, Roy AG. "It is time to classify biological aging as a disease." Frontiers in Genetics, 2015. https://doi.org/10.3389/fgene.2015.00205
  7. ↑ Khaltourina D, Matveyev Y, Alekseev A, Cortese F, Iovita A. "Aging fits the disease criteria of the International Classification of Diseases." Mechanisms of Ageing and Development, 2020. https://doi.org/10.1016/j.mad.2020.111230
  8. ↑ Feltes BC. "Aging is not a disease: an evolutionary and comparative biological reappraisal." Biogerontology, 2026. https://doi.org/10.1007/s10522-026-10422-3
  9. ↑ The Lancet Healthy Longevity. "Is ageing a disease?" Editorial, 2022. https://doi.org/10.1016/S2666-7568(22)00154-4